In a previous study of Japanese patients, Takenaka et al. reported that the ERCC1 C8092A polymorphism may influence NSCLC prognosis regardless of ERCC1 protein expression and platinum sensitivity [15]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.